Association of MRI leptomeningeal enhancement with disability worsening in progressive multiple sclerosis: A clinical and post-mortem study

• Published in: Multiple sclerosis Vol. 29; no. 13; pp. 1526 - 1539
• Main Authors: Vercellino, Marco, Costantini, Gianfranco, Cogoni, Maurizio, Lequio, Laura, Sciortino, Paola, De Negri, Federica, Marasciulo, Stella, Valentini, Consuelo, Bosa, Chiara, Garelli, Paola, Rolando, Anna, Calvo, Andrea, Morana, Giovanni, Cavalla, Paola
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01-11-2023; Sage Publications Ltd
• Subjects: Fibrosis; Inflammation; Magnetic resonance imaging; Meninges; Multiple sclerosis; Progressive multiple sclerosis; meningeal fibrosis; meningeal inflammation; leptomeningeal enhancement; brain volume; disability
• ISSN: 1352-4585; 1477-0970
• DOI: 10.1177/13524585231199031

Background:
Leptomeningeal enhancement (LME) has been described as a biomarker of meningeal inflammation in multiple sclerosis (MS).
Objective:
The aim of this study was to (1) assess if LME is predictive of disability worsening in progressive MS (pMS) patients and (2) investigate the pathological substrates of LME in an independent post-mortem MS series.
Methods:
In total, 115 pMS patients were imaged yearly with 1.5T MRI, using post-contrast CUBE 3D FLAIR for LME detection. Endpoint: to identify the baseline variables predictive of confirmed disability worsening (CDW) at 24 months follow-up. Post-mortem, inflammation, and structural changes of the leptomeninges were assessed in 12 MS/8 control brains.
Results:
LME (27% of patients at baseline) was associated with higher EDSS and lower brain volume (nBV). LME was unchanged in most patients over follow-up. LME at baseline MRI was independently associated with higher risk of 24 months CDW (HR 3.05, 95% CI 1.36–6.84, p = 0.007) in a Cox regression, including age, nBV, T2 lesion volume, high-efficacy treatments, and MRI disease activity. Post-mortem, focal structural changes (fibrosis) of the leptomeninges were observed in MS, usually associated with inflammation (Kendall’s Tau 0.315, p < 0.0001).
Conclusions:
LME is frequently detected in pMS patients using 1.5T MRI and is independently predictive of disability progression. LME could result from both focal leptomeningeal post-inflammatory fibrosis and inflammation.